Research Memo 3
I chose three videos for my blog that I thought would show the most content towards obesity. The first video, called obesity affects. The first video I looked at I liked a lot and used it for various reasons. I thought it showed the most information that I can ever put into words and more. This documentary video explains my entire research topic. It shows some of the short term and long term affects of obesity, it tells us why people are getting more obese and it shows how to do something about obesity in detail.
The second video I chose, called childhood obesity. It talks about what causes childhood obesity and how it affects you through the rest of your life. It goes onto talk about how obesity affects a person’s mood and can negatively affect a person’s mental health and their physical health. It says that obesity can be hereditary but the factors that cause it are the person’s lifestyle and diet. Going on to say that obesity is caused by how lazy a person is and whether they exercise daily or not. For the last part of this video they say for more information go to WeMakeYouKnow.com/child-obesity.
The last video, called the effects and causes of obesity. This video is about the effects and causes of obesity. The video says that obesity is a chronic condition caused by a person’s diet and lifestyle. It shows the long-term consequences of obesity like atherosclerosis and can be increase the rate of some types of cancers like breast cancer. People overweight are also more likely to develop type 2 diabetes, have a direct affect on a person’s blood pressure, and have an impact on the types of diseases that they are more susceptible to. Lastly, overweight women have to go urinate more often than women do, and most overweight people often complain that they have cramps and pains because of the excess weight.
Sunday, November 27, 2011
Wednesday, November 23, 2011
Monday, November 21, 2011
Survey
Obesity in America
1.) Should obese people have to pay more for healthcare?
Yes or No
2.) Do you agree or disagree that restaurants are having healthier foods?
Yes or No
3.) What types of technology do you think make people obese? Check all that apply.
| | Video Games |
| | Computer |
| | Television |
| | Cell Phones |
| | Cars |
| | Other |
4.) How bad do you think obesity is in America on a scale of 1-5 with one being the lowest and five being the highest.
1 2 3 4 5
5.) Should there be laws to help inform people on healthy lifestyles?
Yes or No
6.) True or False obesity does not have long-term effects.
True or False
7.) What age group is most affected by obesity?
Children Teens Adults Elderly
8.) What causes people to be obese?
__ Drugs
__ Depression
__ Emotion
__ Cravings
__ Other
__ None
9.) Do you think obesity should not be a problem that we should worry about?
Yes or no
10.) Is there any additional things you would like to say about obesity?
_______________________________
Works Cited
RESOURCES
National Diabetes Education Program (NDEP) Toll-free: 1-888-693-NDEP (6337). http://www.yourdiabetesinfo.org.
A me r ican A sso ciat io n o f D iab e - tes Educators Toll-free: 800-TEAM-UP4 (1-800-832-6874). http://www.diabetesedu- cator.org.
American Diabetes Association Toll-free:
1-800-DIAbETES (1-800-342-2383). http://
Centers for Disease Control and Preven-
Children with Diabetes Website. http://
REFERENCES
2. Dabelea D, bell RA, D’Agostino Rb, Jr., et al. Incidence of diabetes in youth in the United States. JAMA. 2007;297(24):2716-2724.
3. Ogden CL, Carroll MD, Flegal KM. High body mass index for age among U.S. children and adolescents, 2003-2006. JAMA.
2008;299(20):2401-2405.
4. Fagot-Campagna A, burrows NR, Wil- liamson DF. The public health epidemiology of type 2 diabetes in children and adolescents: a case study of American Indian adolescents in the Southwestern United States. Clin Chim Acta.
1999;286(1-2):81-95.
5. Hunt KJ, Schuller KL. The increasing preva- lence of diabetes in pregnancy. Obste Gynecol Clin North Am. 2007;34(2):173-199.
6. American Diabetes Association Standards of medical care in diabetes-2009. Diabetes Care.
2009;32(Suppl. 1):S13-61.
7. American Diabetes Association. Hyperg- lycemic crises in diabetes (Position statement). Diabetes Care. 2004;27(Suppl. 1):S94-S102.
8. American Diabetes Association. Type 2 diabetes in children and adolescents. Pediatrics.
2000;105(3):671-680.
1. Hendrie HC. Epidemiology of dementia and Alzheimer’s disease. Am J Geriatr Psychiatry 1998; 6: S3–S18.
2. Centers of Disease Control and Prevention. Death: preliminary data 2003. Natl Vital Stat Rep 2001; 49: 1–88.
3. Dewey ME, Saz P. Dementia, cognitive impairment and mor- tality in persons aged 65 and over living in the community: a systematic review of the literature. Int J Geriatr Psychiatry 2001;
16: 751–761.
4. Abate C, Ferrari-Ramondo V, Di Iorio A. Risk factors for cognitive disorders in the elderly: a review. Arch Gerontol Geriatr Suppl 1998; 6: 7–15.
5. Gorospe EC, Dave JK. The risk of dementia with increased body mass index. Age Ageing 2007; 36: 23–29.
6. Wang Y, Beydoun MA. The obesity epidemic in the United States – gender, age, socioeconomic, racial/ethnic, and geographic characteristics. A systematic review and meta-regression analysis. Epidemiol Rev 2007; 29: 6–28.
7. Okosun IS, Choi ST, Boltri JM, Parish DC, Chandra KM, Dever GE, Lucas A. Trends of abdominal adiposity in white, black, and Mexican-American adults, 1988 to 2000. Obes Res 2003; 11:
1010–1017.
8. Luchsinger JA, Patel B, Tang MX, Schupf N, Mayeux R. Mea- sures of adiposity and dementia risk in elderly persons. Arch Neurol 2007; 64: 392–398.
9. Whitmer RA, Gunderson EP, Quesenberry CP Jr, Zhou J, Yaffe K. Body mass index in midlife and risk of Alzheimer disease and vascular dementia. Curr Alzheimer Res 2007; 4: 103–109.
10. Hayden KM, Zandi PP, Lyketsos CG, Khachaturian AS, Bastian LA, Charoonruk G, Tschanz JT, Norton MC, Pieper CF, Munger RG, Breitner JC, Welsh-Bohmer KA. Cache County Inves- tigators: Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study. Alzheimer Dis Assoc Disord 2006; 20: 93–100.
11. Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kareholt I, Winblad B, Helkala EL, Tuomilehto J, Soininen H, Nissinen A. Obesity and vascular risk factors at midlife and the risk of demen- tia and Alzheimer disease. Arch Neurol 2005; 62: 1556–1560.
12. Nourhashemi F, Deschamps V, Larrieu S, Letenneur L, Dart- igues JF, Barberger-Gateau P. Body mass index and incidence of dementia: the PAQUID study. Neurology 2003; 60: 117–119.
Journal compilation © 2008 The International Association for the Study of Obesity. obesity reviews 9, 204–218
14. Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP Jr, Yaffe K. Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ 2005; 330:
1360.
15. Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I. An
18-year follow-up of overweight and risk of Alzheimer disease.
Arch Intern Med 2003; 163: 1524–1528.
16. Yoshitake T, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K, Ohmori S, Nomiyama K, Kawano H, Ueda K, Sueishi K, Tsuneyoshi M, Fujishima, M. Incidence and risk factors of vascular dementia and Alzheimer’s disease in a defined elderly Japanese population: the Hisayama Study. Neurology 1995; 45:
1161–1168.
17. Kalmijn S, Foley D, White L, Burchfiel CM, Curb JD, Petro- vitch H, Ross GW, Havlik RJ, Launer LJ. Metabolic cardiovascu- lar syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study. Arterioscler Thromb Vasc Biol 2000; 20: 2255–2260.
18. Thomson TM. Endnote version X. Philadelphia, PA 2006. URL: http://www.endnote.com/
19. Petitti DB. Statistical methods in meat-analysis. In: Petitti DB (ed.). Meta-Analysis. Decision Analysis, and Cost-Effectiveness Analysis, 2nd edn. Oxford University Press: New York, 2000, pp.
94–118.
20. DerSimonian R, Laird N. Meta-analysis in clinical trials.
Control Clin Trials 1986; 7: 177–188.
21. Egger M, Smith GD, Altman DG. Systematic Reviews in Heatlh Care: Meta-Analysis in Context, 2nd edn. The BMJ Pub- lishing Group: London, 2001.
22. Egger M, Smith GD, Schneider M, Minder C. Bias in meta- analysis detected by a simple, graphical test. BMJ 1997; 315:
629–634.
23. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088–
1101.
24. Stata Statistical Software. Release 9.0. Stata Corporation. College Station, TX. 2005.
25. Razay G, Vreugdenhil A, Wilcock G. Obesity, abdominal obesity and Alzheimer disease. Dement Geriatr Cogn Disord
2006; 22: 173–176.
26. Elmquist JK, Flier JS. Neuroscience. The fat-brain axis enters a new dimension. Science 2004; 304: 63–64.
27. Schaffler A, Binart N, Scholmerich J, Buchler C. Hypothesis paper brain talks with fat – evidence for a hypothalamic-pituitary- adipose axis? Neuropeptides 2005; 39: 363–367.
28. Harvey J, Shanley LJ, O’Malley D, Irving AJ. Leptin: a poten- tial cognitive enhancer? Biochem Soc Trans 2005; 33: 1029–
1032.
29. Bray GA, Popkin BM. Dietary fat intake does affect obesity!.
Am J Clin Nutr 1998; 68: 1157–1173.
30. El-Atat F, Aneja A, McFarlane S, Sowers J. Obesity and hyper- tension. Endocrinol Metab Clin North Am 2003; 32: 823–854.
31. Hall JE, Jones DW, Kuo JJ, da Silva A, Tallam LS, Liu J. Impact of the obesity epidemic on hypertension and renal disease. Curr Hypertens Rep 2003; 5: 386–392.
32. Najman DM, Kapoor P, Serrano A, T ckachenko D. Hyper- tension and obesity. Arch Intern Med 2003; 163: 1114–
1115;author reply 15–16.
34. Glynn RJ, Beckett LA, Hebert LE, Morris MC, Scherr PA, Evans DA. Current and remote blood pressure and cognitive decline. JAMA 1999; 281: 438–445.
35. Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 2004; 61: 661–666.
36. Yaffe K, Blackwell T, Kanaya AM, Davidowitz N, Barrett- Connor E, Krueger K. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology
2004; 63: 658–663.
37. Hassing LB, Hofer SM, Nilsson SE, Berg S, Pedersen NL, McClearn G, Johansson B. Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: evidence from a longi- tudinal study. Age Ageing 2004; 33: 355–361.
38. Burns M, Duff K. Cholesterol in Alzheimer’s disease and tauopathy. Ann N Y Acad Sci 2002; 977: 367–375.
39. Alzheimer’s disease: Translating neurochemical insights into chemical benefits. J Clin Psychiatry 2000; 61: 791–802.
40. Kuriyama M, Takahashi K, Yamano T, Hokezu Y, Togo S, Osame M, Igakura T. Low levels of serum apolipoprotein A I and A II in senile dementia. Jpn J Psychiatry Neurol 1994; 48: 589–
593.
41. Muckle TJ, Roy JR. High-density lipoprotein cholesterol in differential diagnosis of senile dementia. Lancet 1985; 1: 1191–
1193.
42. Kuriyama M, Hokezu Y, Togo S, Nagata K, Takahashi K, Igakura T, Osame M. [Serum lipids, lipoproteins and apolipopro- teins in patients with senile dementia]. Nippon Ronen Igakkai Zasshi 1992; 29: 559–564.
43. Klich-Raczka A, Necki M, Wizner B, Baron T, Adamkiewicz- Piejko A, Gryglewska B, Grodzicki T. [Vascular dementia and systemic changes]. Przegl Lek 2002; 59: 269–271.
44. Wieringa GE, Burlinson S, Rafferty JA, Gowland E, Burns A. Apolipoprotein E genotypes and serum lipid levels in Alzheimer’s disease and multi-infarct dementia. Int J Geriatr Psychiatry 1997;
12: 359–362.
45. Scacchi R, De Bernardini L, Mantuano E, Vilardo T, Donini LM, Ruggeri M, Gemma AT, Pascone R, Corbo RM. DNA poly- morphisms of apolipoprotein B and angiotensin I-converting enzyme genes and relationships with lipid levels in Italian patients with vascular dementia or Alzheimer’s disease. Dement Geriatr Cogn Disord 1998; 9: 186–190.
46. Lesser G, Kandiah K, Libow LS, Likourezos A, Breuer B, Marin D, Mohs R, Haroutunian V, Neufeld R. Elevated serum total and LDL cholesterol in very old patients with Alzheimer’s disease. Dement Geriatr Cogn Disord 2001; 12: 138–
145.
47. Anttila T, Helkala EL, Viitanen M, Kareholt I, Fratiglioni L, Winblad B, Soininen H, Tuomilehto J, Nissinen A, Kivipelto M. Alcohol drinking in middle age and subsequent risk of mild cog- nitive impairment and dementia in old age: a prospective popula- tion based study. Bmj 2004; 329: 539.
48. Michikawa M. Cholesterol paradox: is high total or low HDL
cholesterol level a risk for Alzheimer’s disease? J Neurosci Res
2003; 72: 141–146.
49. Reitz C, Tang MX, Luchsinger J, Mayeux R. Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol 2004; 61: 705–714.
50. Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, Tylavsky FA, Newman AB. The metabolic syndrome, inflammation, and risk of cognitive decline. Jama 2004; 292:
2237–2242.
51. Martins IJ, Hone E, Foster JK, Sunram-Lea SI, Gnjec A, Fuller
SJ, Nolan D, Gandy SE, Martins RN. Apolipoprotein E, choles-
Alzheimer’s disease and cardiovascular disease. Mol Psychiatry
2006; 11: 721–736.
52. Muller M, Tang MX, Schupf N, Manly JJ, Mayeux R, Luchsinger JA. Metabolic syndrome and dementia risk in a mul- tiethnic elderly cohort. Dement Geriatr Cogn Disord 2007; 24:
185–192.
53. Vanhanen M, Koivisto K, Moilanen L, Helkala EL, Hanninen T, Soininen H, Kervinen K, Kesaniemi YA, Laakso M, Kuusisto J. Association of metabolic syndrome with Alzheimer disease: a population-based study. Neurology 2006; 67: 843–847.
54. Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K. Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol 2001; 58: 498–504.
55. Yaffe K, Barnes D, Nevitt M, Lui LY, Covinsky K. A prospective study of physical activity and cognitive decline in elderly women: women who walk. Arch Intern Med 2001; 161: 1703–1708.
56. van Gelder BM, Tijhuis MA, Kalmijn S, Giampaoli S, Nissinen A, Kromhout D. Physical activity in relation to cognitive decline in elderly men: the FINE Study. Neurology 2004; 63:
2316–2321.
57. Weuve J, Kang JH, Manson JE, Breteler MM, Ware JH, Grod- stein F. Physical activity, including walking, and cognitive function in older women. JAMA 2004; 292: 1454–1461.
58. Abbott RD, White LR, Ross GW, Masaki KH, Curb JD, Petrovitch H. Walking and dementia in physically capable elderly men. JAMA 2004; 292: 1447–1453.
59. Lytle ME, Vander Bilt J, Pandav RS, Dodge HH, Ganguli M. Exercise level and cognitive decline: the MoVIES project. Alzhe- imer Dis Assoc Disord 2004; 18: 57–64.
60. Podewils LJ, Guallar E, Kuller LH, Fried LP, Lopez OL, Carlson M, Lyketsos CG. Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study. Am J Epidemiol 2005; 161: 639–651.
61. Schuit AJ, Feskens EJ, Launer LJ, Kromhout D. Physical activ- ity and cognitive decline, the role of the apolipoprotein e4 allele. Med Sci Sports Exerc 2001; 33: 772–777.
62. Verghese J, LeValley A, Derby C, Kuslansky G, Katz M, Hall C, Buschke H, Lipton RB. Leisure activities and the risk of demen- tia in the elderly. N Engl J Med 2003; 348: 2508–2516.
63. Larson EB, Wang L, Bowen JD, McCormick WC, Teri L, Crane P, Kukull W. Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann Intern Med 2006; 144: 73–81.
64. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Aggarwal N, Wilson RS, Scherr PA. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. Jama 2002; 287: 3230–3237.
65. Prince M, Lewis G, Bird A, Blizard R, Mann A. A longitudinal study of factors predicting change in cognitive test scores over time, in an older hypertensive population. Psychol Med 1996; 26:
555–568.
66. Yaffe K, Blackwell T, Gore R, Sands L, Reus V, Browner WS. Depressive symptoms and cognitive decline in nondemented elderly women: a prospective study. Arch Gen Psychiatry 1999;
56: 425–430.
67. Cerhan JR, Folsom AR, Mortimer JA, Shahar E, Knopman DS, McGovern PG, Hays MA, Crum LD, Heiss G. Correlates of cognitive function in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Gerontology 1998; 44:
95–105.
69. Dustman RE, Ruhling RO, Russell EM, Shearer DE, Bonekat HW, Shigeoka JW, Wood JS, Bradford DC. Aerobic exercise training and improved neuropsychological function of older individuals. Neurobiol Aging 1984; 5: 35–42.
70. Spirduso WW. Physical fitness, aging, and psychomotor speed: a review. J Gerontol 1980; 35: 850–865.
71. Gomez-Pinilla F, Dao L, So V. Physical exercise induces
FGF-2 and its mRNA in the hippocampus. Brain Res 1997; 764:
1–8.
72. Cotman CW, Engesser-Cesar C. Exercise enhances and pro- tects brain function. Exerc Sport Sci Rev 2002; 30: 75–79.
73. Wilson RS, Mendes De Leon CF, Bennett DA, Bienias JL, Evans DA. Depressive symptoms and cognitive decline in a com- munity population of older persons. J Neurol Neurosurg Psychia- try 2004; 75: 126–129.
74. Wilson RS, Barnes LL, Mendes de Leon CF, Aggarwal NT, Schneider JS, Bach J, Pilat J, Beckett LA, Arnold SE, Evans DA, Bennett DA. Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology 2002; 59: 364–370.
75. Dufouil C, Fuhrer R, Dartigues JF, Alperovitch A. Longitudi- nal analysis of the association between depressive symptomatology and cognitive deterioration. Am J Epidemiol 1996; 144: 634–
641.
76. Henderson AS, Korten AE, Jacomb PA, Mackinnon AJ, Jorm AF, Christensen H, Rodgers B. The course of depression in the elderly: a longitudinal community-based study in Australia. Psychol Med 1997; 27: 119–129.
77. Bassuk SS, Berkman LF, Wypij D. Depressive symptomatol- ogy and incident cognitive decline in an elderly community sample. Arch Gen Psychiatry 1998; 55: 1073–1081.
78. Geerlings MI, Schoevers RA, Beekman AT, Jonker C, Deeg DJ, Schmand B, Ader HJ, Bouter LM, Van Tilburg W. Depression and risk of cognitive decline and Alzheimer’s disease. Results of two prospective community-based studies in The Netherlands. Br J Psychiatry 2000; 176: 568–575.
79. Buchman AS, Wilson RS, Bienias JL, Shah RC, Evans DA, Bennett DA. Change in body mass index and risk of incident Alzheimer disease. Neurology 2005; 65: 892–897.
80. Buchman AS, Schneider JA, Wilson RS, Bienias JL, Bennett DA. Body mass index in older persons is associated with Alzheimer disease pathology. Neurology 2006; 67: 1949–1954.
81. Barrett-Connor E, Edelstein SL, Corey-Bloom J, Wiederholt WC. Weight loss precedes dementia in community-dwelling older adults. J Am Geriatr Soc 1996; 44: 1147–1152.
82. Kretsch MJ, Green MW, Fong AK, Elliman NA, Johnson HL. Cognitive effects of a long-term weight reducing diet. Int J Obes Relat Metab Disord 1997; 21: 14–21.
83. Morris CH, Hope RA, Fairburn CG. Eating habits in demen- tia. A descriptive study. Br J Psychiatry 1989; 154: 801–806.
84. Cooper JK, Mungas D. Serotonin response in sweet-food craving Alzheimer’s disease subjects. Aging (Milano) 1992; 4: 165–
169.
85. Mungas D, Cooper JK, Weiler PG, Gietzen D, Franzi C, Bernick C. Dietary preference for sweet foods in patients with dementia. J Am Geriatr Soc 1990; 38: 999–1007.
86. Wang PN, Yang CL, Lin KN, Chen WT, Chwang LC, Liu HC. Weight loss, nutritional status and physical activity in patients with Alzheimer’s disease. A controlled study. J Neurol 2004; 251: 314–
320.
87. Nourhashemi F, Andrieu S, Gillette-Guyonnet S, Reynish E, Albarede JL, Grandjean H, Vellas B. Is there a relationship between fat-free soft tissue mass and low cognitive function? Results from a study of 7,105 women. J Am Geriatr Soc 2002; 50:
1796–1801.
Journal compilation © 2008 The International Association for the Study of Obesity. obesity reviews 9, 204–218
88. Strawbridge WJ, Shema SJ, Balfour JL, Higby HR, Kaplan GA. Antecedents of frailty over three decades in an older cohort. J Gerontol B Psychol Sci Soc Sci 1998; 53: S9–S16.
89. Weaver JD, Huang MH, Albert M, Harris T, Rowe JW, Seeman TE. Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology 2002; 59: 371–378.
90. APA. Diagnostic and Statistical Manual of Mental Disorders,
4th edn. American Psychiatric Association: Washington, DC,
1994.
91. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Depart- ment of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984; 34: 939–944.
92. World Health Organization. The ICD-10 Classification of Mental and Behavioral Disorders: Diagnostic Criteria for Research. World Health Organization: Geneva, 1993.
93. Wetterling T, Kanitz RD, Borgis KJ. Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-
10, NINDS-AIREN). Stroke 1996; 27: 30–36.
94. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, Revised. American Psychi- atric Association: Washington, DC, 1987.
95. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, Moody DM, O’Brien MD, Yamaguchi T, Grafman J, Drayer BP, Bennett DA, Fisher M, Ogata J, Kokmen E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, DeCarli C, Culebras A, Korczyn AD, Bogousslavsky J, Hartmann A, Schein- berg P. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology
1993; 43: 250–260.
I. Guilleminault C. Obstructive sleep apnea. The clinical syndrome and historical perspective. Med lin orth Am 1985;
69: 1187-203.
2. Kalra M , lnge T. Garcia V, et al. Obstructive sleep apnea in extremely overweight adolescents undergoing bariatric sur gery. Obes Res 2005; 13:1175-9.
3. Marcus CL. CurtisS, Koerner B. Joffe A. Serwint JR. Loughlin GM. Evaluation of pulmonary function and polysom nography in obese children and adolescents. Pediatr Pulmonol
1996;21 : 176-83.
4. Redline S. Ti hler PV. Schluchtcr M. Ayl r J. lark K . Graham G . Risk factors for leep-di ordered breathing in chi! dren . Associations with obesity. race. and respiratory problems. Am J Respir Crit Care Med 1999;159: 1527-32.
5. Silvestri JM, Weese-Mayer D •. Bass MT, Kenny S. Hauptman SA. Pearsall SM. Polysomnogruphy in obes' chi! dren with a hi story of sleep-associated breathing disorders. Pc· diatr Pulmonol 1993;16: 124-9.
7. A min R . Kimball TR, Kalra M. et al. Left ventricular function in children with sleep-disordered breathing. Am J Car diol 2005;95:80 1 -4.
8. Beebe OW, Gozal D. Obstructive sleep apnea and the prefrontal cortex: towards a comprehensive model linking n c turnalupper airway obstruction to daytime cognitive and behav IOral defici ts. J Sleep Res 2002; II : 1 -16.
9. Beebe OW. Wells T.JcffriesJ.Chini B. Kalra M ,A min R . Neuropsychological effects of pediatric obstructive sleep ap nea. J lnt Ne uropsychol Soc 2004; I 0:962-75.
10. de Ia Eva RC. Baur LA , Donaghue K . Waters KA . Met abolic correlates with obstructive s l eep apnea in obese subjects. J Pediatr 2002:140:654-9.
II . 1\.alra M. Kumar , hakraborty R . Fitz K. Wilson K, ln ge T. Association of obstructive sleep apnea with hyperinsu linem ia in adolescents with severe obesity. Minerva Pneumol
12. Red!me , torfer-Isse r A, Rosen CL. et al. Association between metabolic syndrome and s leep-disordered breathing in adol ·sce nt. Am J Respir Crit are Med 2007;176:401 -8.
11. Waters KA , Mast BT, Vella , et al. Structural equation modeling of sleep apnea, inflammation , and metabolic dysfunc tiOn in children. J Sleep Res 2007;1 6:388-95.
14. Malhotra A, White DP. Obstructive sleep apnoea. Lancet
2002:360:237-45.
15. Liao YF. huang ML, Huang S. Tsai YY. Upper airway and Its surroundin g structures in obese and nonobese patients
with sl eep-d i ordered breathing. Laryngoscope 2004:114: I 052-
9.
16. Malhotra A. Huang Y. Fogel RB . et .tl The male predis pos ition to pharyngea l collapse: importance of airway length. Am J Respir Crit Care Med 2002; 166: 1 188 95.
17. Ronen 0. Malhotra A. Pillar G. Influence of gender and age on upper-a irway length during dewlopment. Pediatrics
2007; 120:e I 028-e 1034.
18. Sulit LG . torfer- lsser A, Rosen L 1\.irchner HL, Red line . Associations of obesity. sleep-di orducd breathing, and wheezing in children.Am J Re pir rit arc Med 2005:171:659-
64.
19. Rechtschaffen A, Kales A. A manual of tundardizcd ter minology. Techniques and scoring systems for leep stages of human s ubjects. Los Angeles. Calif: UCLA Brain Information Service, Brain Research Institute. 1968.
20. Sleep-related breathin g disorders in adults: rc ommen dations for sy ndrome definition and measurement techniques in clinical research. The report of an American Academ)' of Jeep Medicine task force. Sleep 1999:22:667 89
21. Kuczmarsk i RJ. Ogden CL. Guo SS. et al. 2000 CDC growth charts for the United tates: methods and development. Vital Hea lth Stat II 2002: 1 - 190.
22. Mihaesc u M , Muruga ppan , Gutmark E. Donnelly LF. Kalra M . Computational modelin g of upper airway bcl()re and after adenotonsillectomy for obstructive sleep apnea. Laryngo scope 2008; 118:360-2.
23. Mihaesc u M. Murugappan , Gutmark E. Donnelly LF, Khosla S, Kalra M . Computational fluid dynJmics an.tlysis of upper airway reconstructed from mag netil resonance Imaging data. Ann Otol Rhino! Laryngol 2008:11 7:309.
Subscribe to:
Posts (Atom)